Login
Users of this system, can login to view this document.
Enter the following information to request a copy of the document from the responsible person.
MID-TERM ORAL ISOTRETINOIN THERAPY CAUSES A PREDOMINANTLY SENSORY DEMYELINATING NEUROPATHY